2-bromo-5-methyl-7,9,10,14b-tetrahydroisoquinolino[2,1-d][1,4]benzodiazepin-6-one
- Molecular formula
- C18H17BrN2O
- CAS Number
- 150322-43-3
- IUPAC Name
- 2-bromo-5-methyl-7,9,10,14b-tetrahydroisoquinolino[2,1-d][1,4]benzodiazepin-6-one
- Molecular Weight
- 358.27g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.6150g/cm3
- Appearance
- may vary slightly based on purity and form.
- Synonyms
- 19007-20-6
Identification
Interesting Facts about 2-bromo-5-methyl-7,9,10,14b-tetrahydroisoquinolino[2,1-d][1,4]benzodiazepin-6-one
The compound 2-bromo-5-methyl-7,9,10,14b-tetrahydroisoquinolino[2,1-d][1,4]benzodiazepin-6-one belongs to a fascinating class of chemical compounds known as benzodiazepines, which are primarily recognized for their psychoactive effects. Here are some interesting facts about this compound:
- Structure Complexity: The intricate structure of this compound includes multiple fused rings, contributing to its potential bioactivity and versatility in medicinal chemistry.
- Pharmacological Relevance: Compounds of similar structure are often evaluated for their therapeutic properties, particularly in the treatment of anxiety, insomnia, and other central nervous system disorders.
- Bridging Chemical Classes: This compound uniquely bridges the isoquinoline and benzodiazepine classes, which could lead to interesting interactions and effects different from typical benzodiazepines.
- Potential Research Application: The presence of the bromine atom suggests that substitution might affect the compound’s reactivity and interaction with biological targets, making it a subject of interest for synthesis and modification in laboratories.
- Synthetic Pathways: The complexity of synthesizing such a compound not only poses challenges but also encourages innovative approaches in organic synthesis, promoting the development of new methodologies.
In the words of a notable chemist, “The beauty of chemistry lies in its ability to transform simple building blocks into complex structures that can have profound effects.” Understanding compounds like 2-bromo-5-methyl-7,9,10,14b-tetrahydroisoquinolino[2,1-d][1,4]benzodiazepin-6-one offers insights into the rich possibilities in both the realms of pharmaceuticals and synthetic chemistry. The exploration of such compounds can potentially lead to breakthroughs in drug design and therapeutic applications.